Widely acclaimed as a breakthrough in reducing maternal mortality ratios, tranexamic acid offers a glimmer of hope to the millions of women around the world at risk of dying during childbirth every year. This new drug presents clear evidence that we have the knowledge and technology to save lives: the challenge now is its distribution and effective implementation in regions at greatest risk.
Previously used to reduce heavy menstrual periods in Western countries, tranexamic acid has been in medical use since its discovery in Japan in the 1960s. But in April of this year, an extensive trial conducted by the London School of Tropical Medicine and Hygiene revealed a more far-reaching use of the drug, which has the effect of stopping blood clots from breaking down.
Read more: http://news.trust.org/item/20170605120113-m2fbz